tiprankstipranks
Claritas Pharmaceuticals (CLAZF)
OTHER OTC:CLAZF

Claritas Pharmaceuticals (CLAZF) Financial Statements

25 Followers

Claritas Pharmaceuticals Financial Overview

Claritas Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Claritas Pharmaceuticals is scheduled to report earnings on June 2, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 21Jun 21Mar 21Dec 20Sep 20
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ 195.00K$ -549.00K$ -2.72M$ -1.84M$ 210.00K
EBITDA$ 195.00K$ -549.00K$ -2.72M$ -1.84M$ 210.00K
Net Income Common Stockholders--$ -2.30M$ -654.00K$ -413.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.00K$ 282.00K$ 28.00K$ 5.00K$ 490.00K
Total Assets$ 11.02M$ 11.15M$ 8.11M$ 10.45M$ 10.88M
Total Debt$ 548.00K$ 1.24M$ 406.00K$ 925.00K$ 895.00K
Net Debt$ 546.00K$ 954.00K$ 378.00K$ 920.00K$ 405.00K
Total Liabilities$ 7.74M$ 8.39M$ 7.93M$ 8.94M$ 8.62M
Stockholders Equity$ 3.28M$ 2.76M$ 176.00K$ 1.51M$ 2.27M
Cash Flow-
Free Cash Flow--$ -324.00K$ -484.00K$ 267.00K
Operating Cash Flow$ -281.00K$ 136.00K$ -324.00K$ -484.00K$ 267.00K
Investing Cash Flow--$ 0.00-$ 0.00
Financing Cash Flow$ 1.00K$ 118.00K$ 347.00K-$ 212.00K
Currency in USD

Claritas Pharmaceuticals Earnings and Revenue History

Claritas Pharmaceuticals Debt to Assets

Claritas Pharmaceuticals Cash Flow

Claritas Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis